Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC spermicides monograph should be based in part on forthcoming NICHD data -- NDMA.

This article was originally published in The Tan Sheet

Executive Summary

SPERMICIDES MONOGRAPH BASED IN PART ON NICHD TRIAL URGED BY NDMA in a "position paper" submitted to FDA Nov. 4. The products used in the planned National Institute of Child Health & Human Development trial could be employed by the United States Pharmacopoeia to develop a reference standard system for OTC spermicides, and data from the study could "be reviewed by FDA and incorporated into the final monograph," the Nonprescription Drug Manufacturers Association suggested.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086361

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel